Results 181 to 190 of about 14,184,553 (374)
Se reevaluó el rango de referencia del tiempo parcial de tromboplastina activada (TPTA). Se obtuvo un rango de referencia de 29 a 40 seg. con una media () de 34,01 seg.
Alina Díaz Concepción+2 more
doaj
Mitochondria contain two mitoribosome rescue factors, ICT1 and MTRFR (C12orf65). ICT1 also functions as a mitoribosomal protein in mice and humans, and its loss is lethal. Although Mtrfr knockout mice could not be generated, knockout zebrafish lines for ict1 and mtrfr were established.
Nobukazu Nameki+11 more
wiley +1 more source
Many investigations have proved relations between ABO blood groups with some diseases and factor VIII and von willebrand level in plasma. In this study we investigated a relation between ABO blood groups and factor VIII and IX inhibitors in 102 patients ...
Hassan Mansouri Torghabeh+3 more
doaj
Protoporphyrin IX Extraction From Quail Eggshell (Cortunix Cortunix) and Its Complexity with Zn(II) [PDF]
The aim of this research is to find the optimal condition for Zn(II) complexation with protoporphyrin IX which is a natural coloring pigment on quail eggshell. The concentration of protoporphyrin IX extract is 0.01% (w / w) of the dried extract.
Laksono, A. R. (A)+2 more
core
Five‐year evaluation of linear accelerator‐based SRS platform isocentricity
Abstract Linear accelerator (LINAC)‐based stereotactic radiosurgery (SRS) has become a mainstay in the management of intracranial tumors. However, the high fractional doses and sharp gradients used in SRS place heavy demands on geometric accuracy.
Yohan A. Walter+3 more
wiley +1 more source
New developments in the management of moderate-to-severe hemophilia B
Moniba Nazeef,1,2 John P Sheehan1,2 1Department of Medicine, Division of Hematology/Oncology, 2UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA Abstract: Hemophilia B is an X-linked genetic ...
Nazeef M, Sheehan JP
doaj
Abstract Purpose Cardiotoxicity is one of the major concerns in breast cancer treatment, significantly affecting patient outcomes. To improve the likelihood of favorable outcomes for breast cancer survivors, it is essential to carefully balance the potential advantages of treatment methods with the risks of harm to healthy tissues, including the heart.
Amin Talebi+6 more
wiley +1 more source
Factor IX in Intravascular and Extravascular Blood Coagulation
F.J.W. Lewis, F. Nour‐Eldin
openalex +1 more source